- জেনেরিক নাম
- Ciprofibrate
- শক্তি
- 100 mg
- ডোজ ফর্ম
- Tablet
- প্রস্তুতকারক
- Opsonin Pharma Limited
Cifirate 100 Tablet
Cifirate 100 Tablet সম্পর্কে
Cifirate 100 হলো Ciprofibrate-এর একটি ব্র্যান্ড, শক্তি ১০০ mg, ট্যাবলেট আকারে। Cifirate 100 প্রস্তুত করেছে Opsonin Pharma Limited। Cifirate 100-এর সাথে Ciprofibrate-এর অন্য ব্র্যান্ডের দাম নিচে তুলনা করে দেখুন। এই তথ্য শুধু জানার জন্য; ঔষধ সবসময় ডাক্তারের পরামর্শ অনুযায়ী খাবেন, মাত্রা বা ব্র্যান্ড নিয়ে প্রশ্ন থাকলে ফার্মাসিস্টকে জিজ্ঞেস করুন।
Ciprofibrate-এর ২টি ব্র্যান্ড বাংলাদেশে তালিকাভুক্ত।
Cifirate 100 Tablet কী?
Made by Opsonin Pharma Limited, Cifirate 100 is a tablet whose active ingredient is Ciprofibrate. Ciprofbrate reduces both LDL & VLDL and hence the levels of triglyceride and cholesterol associated with these lipoprotein fractions. There is evidence that treatment with fibrates may reduce coronary heart disease events. Whether it suits you is a decision for your doctor.
Cifirate 100-এর ব্যবহার
Mixed hyperlipidemia when a statin is contraindicated or not tolerated. Ciprofbrate is indicated as an adjunct to diet, exercise and weight reduction for the following: Treatment of severe hypertriglyceridemia with or without low HDL cholesterol. Your doctor will decide if it is suitable for you.
Cifirate 100 কীভাবে ব্যবহার করবেন
Cifirate 100 is taken by mouth. Swallow the tablet with water. Do not change the dose or stop early without asking your doctor. If you miss a dose, ask your doctor or pharmacist what to do.
Cifirate 100-এর পার্শ্বপ্রতিক্রিয়া
Headache, Dizziness, Somnolence, Vertigo, Nausea, Vomiting, Diarrhoea, Dyspepsia, Abdominal pain, Rash, Alopecia, Myalgia, Fatigue. Contact your doctor if you notice anything unusual after taking it. Tell your doctor if any side effect bothers you or does not go away.
সতর্কতা ও নিরাপত্তা
Myalgia/myopathy : Patients should be advised to report unexplained muscle pain, tenderness or weakness immediately. There is no evidence that Ciprofbrate is teratogenic but signs of toxicity at high doses were observed in teratogenicity tests in animals. Special warnings : Patients with rare hereditary problems of galactose intolerance, lactose deficiency or glucose-galactose malabsorption should not take this medicine. Ask your doctor first if any of these apply to you.
সাধারণ প্রশ্ন
Why is Cifirate 100 prescribed?
Mixed hyperlipidemia when a statin is contraindicated or not tolerated. Ciprofbrate is indicated as an adjunct to diet, exercise and weight reduction for the following: Treatment of severe hypertriglyceridemia with or without low HDL cholesterol.
How do I use Cifirate 100 correctly?
Cifirate 100 is taken by mouth. Swallow the tablet with water.
Can Cifirate 100 cause side effects?
Headache, Dizziness, Somnolence, Vertigo, Nausea, Vomiting, Diarrhoea, Dyspepsia, Abdominal pain, Rash, Alopecia, Myalgia, Fatigue. Contact your doctor if you notice anything unusual after taking it.
Is Cifirate 100 safe for everyone?
Myalgia/myopathy : Patients should be advised to report unexplained muscle pain, tenderness or weakness immediately. There is no evidence that Ciprofbrate is teratogenic but signs of toxicity at high doses were observed in teratogenicity tests in animals.
নির্দেশনা
এই লেখার বাংলা এখনো নেই; ইংরেজি লেখা দেখানো হচ্ছে।
Ciprofbrate is indicated as an adjunct to diet, exercise and weight reduction for the following:- Treatment of severe hypertriglyceridemia with or without low HDL cholesterol.
- Mixed hyperlipidemia when a statin is contraindicated or not tolerated.
ফার্মাকোলজি
এই লেখার বাংলা এখনো নেই; ইংরেজি লেখা দেখানো হচ্ছে।
Ciprofbrate reduces both LDL & VLDL and hence the levels of triglyceride and cholesterol associated with these lipoprotein fractions. It also increases levels of HDL cholesterol. Ciprofbrate is effective in the treatment of hyperlipidemia associated with high plasma concentrations of LDL and VLDL. There is evidence that treatment with fibrates may reduce coronary heart disease events.মাত্রা ও সেবনবিধি
এই লেখার বাংলা এখনো নেই; ইংরেজি লেখা দেখানো হচ্ছে।
Adults: The recommended dose is Ciprofbrate 100 mg per day. This dose should not be exceeded.Patients with renal insufficiency: In moderate renal impairment (creatinine clearance 30-80 ml/min/1.73 m2) it is recommended that dosage be reduced to one tablet every other day. Patients should be carefully monitored. Ciprofbrate should not be used in severe renal impairment (creatinine clearance <30 ml/min/1.73 m2).
Patients with hepatic insufficiency: Use with caution in patients with impaired hepatic function. Ciprofbrate treatment should be discontinued in case of increased AST and ALT levels to more than 3 times the upper limit of normal or if cholestatic liver injury is evidenced.
Elderly: As for adults but precautions should be taken for Age more than 70 years.
Paediatric population: Not recommended since safety and efficacy in children has not been established.
ঔষধের মিথষ্ক্রিয়া
এই লেখার বাংলা এখনো নেই; ইংরেজি লেখা দেখানো হচ্ছে।
Other fibrates & HMG CoA reductase inhibitors: As Risk of myopathy, rhabdomyolysis and myoglobinuria may be increased if Ciprofbrate is used in combination with other fibrates and HMG CoA reductase inhibitors.Oral anticoagulant therapy: Caution should be exercised when Ciprofbrate is taken with oral anticoagulants. Concomitant oral anticoagulant therapy should be given at a reduced dosage and adjusted according to INR.
প্রতিনির্দেশনা
এই লেখার বাংলা এখনো নেই; ইংরেজি লেখা দেখানো হচ্ছে।
- Hypersensitivity to the active substance or to any of the excipients
- Severe hepatic impairment
- Severe renal impairment (creatinine clearance <30 ml/min/1.73 m2)
- Pregnancy and lactation or when pregnancy is suspected
- Concurrent use with another fibrate
পার্শ্ব প্রতিক্রিয়া
এই লেখার বাংলা এখনো নেই; ইংরেজি লেখা দেখানো হচ্ছে।
Headache, Dizziness, Somnolence, Vertigo, Nausea, Vomiting, Diarrhoea, Dyspepsia, Abdominal pain, Rash, Alopecia, Myalgia, Fatigue.গর্ভাবস্থায় ও স্তন্যদানকালে
এই লেখার বাংলা এখনো নেই; ইংরেজি লেখা দেখানো হচ্ছে।
There is no evidence that Ciprofbrate is teratogenic but signs of toxicity at high doses were observed in teratogenicity tests in animals. As there are no data on its use in human pregnancy, Ciprofbrate is contraindicated during pregnancy. As there are no data on its use in lactation, Ciprofbrate is contraindicated in nursing mothers.সতর্কতা
এই লেখার বাংলা এখনো নেই; ইংরেজি লেখা দেখানো হচ্ছে।
Special warnings: Patients with rare hereditary problems of galactose intolerance, lactose deficiency or glucose-galactose malabsorption should not take this medicine.Myalgia/myopathy: Patients should be advised to report unexplained muscle pain, tenderness or weakness immediately.
Patients with impaired hepatic function: Periodic hepatic function tests are recommended (every 3 months for the first 12 months of treatment). Ciprofbrate treatment should be discontinued in case of increased AST and ALT levels to more than 3 times the upper limit of normal or if cholestatic liver injury is evidenced.
সংরক্ষণ
এই লেখার বাংলা এখনো নেই; ইংরেজি লেখা দেখানো হচ্ছে।
Store below 30°C. Protect from light and moisture. Keep the medicine out of reach of children.বিকল্প ব্র্যান্ড: Ciprofibrate
একই জেনেরিকের অন্য ব্র্যান্ড, কম দাম আগে।
ঔষধের তথ্য শুধু জানার জন্য, এটি চিকিৎসা পরামর্শ নয়। সবসময় ডাক্তারের প্রেসক্রিপশন মানুন এবং ফার্মাসিস্টের সাথে কথা বলুন।